The other really interesting new information for me was the expansion of the variants for BTM and MTX based on physician requests (market feedback)
1. Different thickness options for different parts of the body was a great opportunity to broaden the market for both BTM and MTX. 2. The larger 40cm format for large surface area wounds. 3. The roll package option for ease if continuous application around limbs and torso for better coverage with less joins. 4. The addition of antibacterial coating to the Novosorb matrix. This means that not only is it non-biologic and takes away the "food" for the bugs, but it also can actively treat residual infection as a default. This will improve the tolerance to dirty wounds from good to great and provide a value big add at low cost.
PNV Price at posting:
$2.61 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)